LISAvienna - Connecting Life Sciences

LISAvienna is a joint life science platform operated by Austria Wirtschaftsservice and the Vienna Business Agency. On behalf of the Austrian Federal Ministry of Labour and Economy and the City of Vienna, it contributes to the advancement of life sciences in Vienna. LISAvienna supports innovative biotech, pharmaceutical, medical device and digital health companies in Vienna that develop and market new products, services and processes. The platform links these companies with development partners and key customers. As a central knowledge carrier, LISAvienna provides input for decisions to advance the life sciences in Vienna and contributes to positioning the city of Vienna as one of the leading European innovation centers.

LISAvienna in numbers

21 Years
Free Services
Newsletters published
Source: LISAvienna (Data: 2002-2022)

The LISAvienna team

The Managing Directors Johannes Sarx (aws) and Philipp Hainzl (Vienna Business Agency) manage the platform. The core team of LISAvienna includes:

The highest-ranking body of LISAvienna is the supervisory board (ARGE Rat), in which both LISAvienna partners are represented. The ARGE Rat makes decisions regarding the further development of the consortium. Tanja Spennlingwimmer is a member of this committee as a representative of Austria Wirtschaftsservice, while the Vienna Business Agency is represented by Eva Czernohorszky.

We provide you with personalized support

Our network

LISAvienna’s network includes a growing number of innovative companies and research institutions from Vienna, especially those focusing on biotech, pharmaceuticals, the bioeconomy, medical devices and digital health solutions. Enter the network by arranging an individual consulting meeting with the LISAvienna team and by attending our events – no formal membership is required.

Of course, we also collaborate with business associations and academic societies in the life sciences. Because of its special owner structure, LISAvienna is also closely connected with funding bodies and investors.